CADILAHC Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > cadilahc

Technical Analysis

Technical Strength: 6.75 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 57.1. According to RSI analysis, cadilahc is technically strong. 9.0 CADILAHC RSI Chart
MACD (?) MACD: 6.84 and Signal Line: 7.24. According to MACD analysis, cadilahc is marginally weak. 3.0 CADILAHC MACD Chart
Simple Moving Average (?) According to simple moving average analysis, cadilahc is in a strong uptrend. Major support levels are 330.755, 310.315, 264.6513. 10.0 CADILAHC Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, cadilahc is in a strong uptrend. Major support levels are 331.7159, 315.1929, 284.8296. 10.0 CADILAHC Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.745. 5.0 CADILAHC Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA CADILAHC Fibonacci Retracement Chart
Average True Range (?) ATR: 13.5 NA CADILAHC Average True Range Chart
Average Directional Index (?) ADX is 29.4 which means CADILAHC is in a trend. NA CADILAHC Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
May 28, 2020
Open Price 336.6
High Price 342.9
Low Price 333.35
Close Price 338.1
Absolute Change 0.5
Percentage Change 0.148%
Weekly Change 0.0888%
Monthly Change 3.73%
Yearly Change 35.4%
52-week high 374.0
52-week low 202.0
Corporate Actions
ExDate Purpose
March 23, 2020 INT DIV-RS 3.50 PER SH
March 23, 2020 INTERIM DIVIDEND
July 25, 2019 AGM/DIV-RS 3.50 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.451
Confidence in Beta2.43%
Market Capital Rs. 6922.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 28 May 2020: Deliverable Quantity:6.14e+05 NA CADILAHC Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 28 May 2020: Daily Volatility:0.5254 NA CADILAHC Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 28 May 2020: PCR_OI:0.479 PCR:0.333 NA CADILAHC PCR Chart
Option Pain (?) 28 May 2020: Max Pain:340.0 NA CADILAHC Option Pain Chart
Premium (?) 28 May 2020 Premium: -0.75 Futures OI:305800.0 NA CADILAHC Premium Chart
Option_MAX_OI (?) 28 May 2020: Price:338.1 Put with maximum OI:300.0 Call with maximum OI:350.0 NA CADILAHC Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
May 28, 2020 337.35 305800.0 2113.0 2113.0 338.1
June 25, 2020 337.3 6419600.0 3317.0 3317.0 338.1
July 30, 2020 334.95 66000.0 18.0 18.0 338.1

Announcements

June 28, 2019 Related Party Transactions Cadila Healthcare Limited has informed the Exchange regarding Half yearly disclosure of Related Party transactions under Reg 23(9) of SEBI (LODR), 2015.
April 26, 2018 CaPress Releaseadila Healthcare Limited has informed the Exchange regarding a press release dated April 25, 2018, titled "Zydus receives final approval from the USFDA for Methylprednisolone Tablets USP and Cinacalcet Hydrochloride Tablets".
See all Announcements

Board Meetings

Date Meeting Date Purpose
March 11, 2020 March 16, 2020 Dividend To consider interim dividend
January 17, 2020 February 05, 2020 Financial Results To consider and approve the financial results for the period ended December 31, 2019
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play